These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35192418)

  • 1. Piquing our interest: Insights into the role of PEAK3 in signaling and disease.
    Paul MD; Torosyan H; Jura N
    Sci Signal; 2022 Feb; 15(722):eabm9396. PubMed ID: 35192418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3.
    Torosyan H; Paul MD; Forget A; Lo M; Diwanji D; Pawłowski K; Krogan NJ; Jura N; Verba KA
    Nat Commun; 2023 Jun; 14(1):3543. PubMed ID: 37336883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEAK3/C19orf35 pseudokinase, a new NFK3 kinase family member, inhibits CrkII through dimerization.
    Lopez ML; Lo M; Kung JE; Dudkiewicz M; Jang GM; Von Dollen J; Johnson JR; Krogan NJ; Pawłowski K; Jura N
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15495-15504. PubMed ID: 31311869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PEAK family of pseudokinases, their role in cell signalling and cancer.
    Patel O; Roy MJ; Murphy JM; Lucet IS
    FEBS J; 2020 Oct; 287(19):4183-4197. PubMed ID: 31599110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.
    Hou J; Nguyen EV; Surudoi M; Roy MJ; Patel O; Lucet IS; Ma X; Daly RJ
    Sci Signal; 2022 Feb; 15(722):eabj3554. PubMed ID: 35192416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling.
    Roy MJ; Surudoi MG; Kropp A; Hou J; Dai W; Hardy JM; Liang LY; Cotton TR; Lechtenberg BC; Dite TA; Ma X; Daly RJ; Patel O; Lucet IS
    Nat Commun; 2023 Jun; 14(1):3542. PubMed ID: 37336884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHED-Dependent Oncogenic Signaling of the PEAK3 Pseudo-Kinase.
    Ounoughene Y; Fourgous E; Boublik Y; Saland E; Guiraud N; Recher C; Urbach S; Fort P; Sarry JE; Fesquet D; Roche S
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and purification of the PEAK pseudokinases for structural and functional studies.
    Patel O; Surudoi M; Dai W; Hardy JM; Roy MJ; Lucet IS
    Methods Enzymol; 2022; 667():1-35. PubMed ID: 35525538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homo- and Heterotypic Association Regulates Signaling by the SgK269/PEAK1 and SgK223 Pseudokinases.
    Liu L; Phua YW; Lee RS; Ma X; Jenkins Y; Novy K; Humphrey ES; Chan H; Shearer R; Ong PC; Dai W; Saunders DN; Lucet IS; Daly RJ
    J Biol Chem; 2016 Oct; 291(41):21571-21583. PubMed ID: 27531744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the evolutionary conservation of the sole PIKK pseudokinase Tra1/TRRAP.
    Elías-Villalobos A; Fort P; Helmlinger D
    Biochem Soc Trans; 2019 Dec; 47(6):1597-1608. PubMed ID: 31769470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the HER3 pseudokinase domain with small molecule inhibitors.
    Colomba A; Claus J; Gao F; George R; Fornili A; Cameron AJM
    Methods Enzymol; 2022; 667():455-505. PubMed ID: 35525551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day of the dead: pseudokinases and pseudophosphatases in physiology and disease.
    Reiterer V; Eyers PA; Farhan H
    Trends Cell Biol; 2014 Sep; 24(9):489-505. PubMed ID: 24818526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into functional connectivity in mammalian signal transduction pathways by pairwise comparison of protein interaction partners of critical signaling hubs.
    Ramana CV
    Biomol Concepts; 2022 Jan; 13(1):298-313. PubMed ID: 36048718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flipping ATP to AMPlify Kinase Functions.
    Sheetz JB; Lemmon MA
    Cell; 2018 Oct; 175(3):641-642. PubMed ID: 30340038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dawn of the dead: protein pseudokinases signal new adventures in cell biology.
    Eyers PA; Murphy JM
    Biochem Soc Trans; 2013 Aug; 41(4):969-74. PubMed ID: 23863165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells.
    Gentile A; Lazzari L; Benvenuti S; Trusolino L; Comoglio PM
    Int J Cancer; 2014 Nov; 135(10):2305-16. PubMed ID: 24706440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It Takes a Village to Overcome KRAS Dependence in Pancreatic Cancer.
    Carr RM; Fernandez-Zapico ME
    Cancer Discov; 2020 Jul; 10(7):910-912. PubMed ID: 32611735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trapping Tribbles: Nanobody-assisted structure of the TRIB2 pseudokinase.
    Santana FR; Linossi EM; Jura N
    Structure; 2022 Nov; 30(11):1465-1467. PubMed ID: 36332608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence without catalysis: how can a pseudokinase affect host cell signaling?
    Reese ML; Boyle JP
    Trends Parasitol; 2012 Feb; 28(2):53-7. PubMed ID: 22257555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The secret life of kinases: insights into non-catalytic signalling functions from pseudokinases.
    Jacobsen AV; Murphy JM
    Biochem Soc Trans; 2017 Jun; 45(3):665-681. PubMed ID: 28620028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.